StockGlow

PureTech Health plc (PRTCY)

Develops early-stage drugs for lung disease, depression, and neurological conditions

$15.55-0.04%Healthcare
Compare PRTCY with
StockGlow Score
14
Bearish
BearishBullish
1 year ago-18.5%

The outlook

PRTCY is trading near the lower end of its 52-week range and below both its 50- and 200-day moving averages, signaling a weak near-term trend. Analyst coverage appears thin or unavailable. The overall sentiment leans bearish based on current technical positioning.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range19% of the way from its 52-week low to high
Market cap
$378.5M
52-wk high
$19.92
52-wk low
$14.50
50-day avg
$17.15
200-day avg
$17.19
Trailing P/E
—

Similar stocks

SLNSilence Therapeutics plc$11.55-4.31%KROSKeros Therapeutics, Inc.$10.07-1.37%MOLNMolecular Partners AG$3.83-4.36%PHARPharming Group N.V.$12.86-1.18%PMVPPMV Pharmaceuticals, Inc.$1.10-6.78%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy